Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-46.37M.
ENTERPRISE VALUE (EV)
$-46.37M
Tenax Therapeutics, Inc.
Market Cap
$51.19M
Enterprise Value (EV)
$-46.37M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Tenax Therapeutics, Inc. (TENX) | $51.19M | $-46.37M |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | $46.67M |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | $41.63M |
| ImageneBio Inc (IMA)vs › | $51.88M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A |
| biote Corp. (BTMD)vs › | $50.28M | $167.75M |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | $31.40M |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | $56.14M |
| INmune Bio, Inc. (INMB)vs › | $49.71M | $32.71M |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | $55.10M |
Market Cap
$51.19M
Total Debt
$0.00
Cash
$97.56M
Enterprise Value
$-46.37M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
